180 related articles for article (PubMed ID: 37774055)
21. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis.
Ono K; Abe T; Oshita A; Sumi Y; Yano T; Okuda H; Kurayoshi M; Kobayashi T; Ohdan H; Noriyuki T; Nakahara M
World J Surg Oncol; 2021 Apr; 19(1):97. PubMed ID: 33820549
[TBL] [Abstract][Full Text] [Related]
22. Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases.
Ruzzenente A; Bagante F; Ratti F; Beal EW; Alexandrescu S; Merath K; Makris EA; Poultsides GA; Margonis GA; Weiss MJ; Popescu I; Aldrighetti L; Guglielmi A; Pawlik TM
HPB (Oxford); 2019 Sep; 21(9):1230-1239. PubMed ID: 30792047
[TBL] [Abstract][Full Text] [Related]
23. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.
DʼAngelica MI; Correa-Gallego C; Paty PB; Cercek A; Gewirtz AN; Chou JF; Capanu M; Kingham TP; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR; Kemeny N
Ann Surg; 2015 Feb; 261(2):353-60. PubMed ID: 24646562
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
26. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
27. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
[TBL] [Abstract][Full Text] [Related]
28. Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.
Nagayama S; Hasegawa S; Hida K; Kawada K; Hatano E; Nakamura K; Seo S; Taura K; Yasuchika K; Matsuo T; Zaima M; Kanazawa A; Terajima H; Tada M; Adachi Y; Nishitai R; Manaka D; Yoshimura T; Doi K; Horimatsu T; Mitsuyoshi A; Yoshimura K; Niimi M; Matsumoto S; Sakai Y; Uemoto S
Int J Clin Oncol; 2017 Apr; 22(2):316-323. PubMed ID: 27752787
[TBL] [Abstract][Full Text] [Related]
29. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
[TBL] [Abstract][Full Text] [Related]
30. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
[TBL] [Abstract][Full Text] [Related]
31. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases.
Buisman FE; van der Stok EP; Galjart B; Vermeulen PB; Balachandran VP; Coebergh van den Braak RRJ; Creasy JM; Höppener DJ; Jarnagin WR; Kingham TP; Nierop PMH; Sadot E; Shia J; Groot Koerkamp B; Grünhagen DJ; D'Angelica M; Verhoef C
Clin Exp Metastasis; 2020 Oct; 37(5):593-605. PubMed ID: 32691187
[TBL] [Abstract][Full Text] [Related]
32. The clinical risk score predicts the effectiveness of adjuvant chemotherapy for colorectal liver metastasis.
Nakai T; Ishikawa H; Tokoro T; Okuno K
World J Surg; 2015 Jun; 39(6):1527-36. PubMed ID: 25677009
[TBL] [Abstract][Full Text] [Related]
33. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
[TBL] [Abstract][Full Text] [Related]
34. Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
Ayez N; de Ridder J; Wiering B; Oyen WJ; de Wilt JH; Verhoef C
Dig Surg; 2013; 30(4-6):451-8. PubMed ID: 24458160
[TBL] [Abstract][Full Text] [Related]
35. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
Liang YH; Shao YY; Chen HM; Cheng AL; Lai MS; Yeh KH
Anticancer Res; 2017 Dec; 37(12):7095-7104. PubMed ID: 29187501
[TBL] [Abstract][Full Text] [Related]
36. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases.
Shindoh J; Loyer EM; Kopetz S; Boonsirikamchai P; Maru DM; Chun YS; Zimmitti G; Curley SA; Charnsangavej C; Aloia TA; Vauthey JN
J Clin Oncol; 2012 Dec; 30(36):4566-72. PubMed ID: 23150701
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases.
Ninomiya M; Emi Y; Motomura T; Tomino T; Iguchi T; Kayashima H; Harada N; Uchiyama H; Nishizaki T; Higashi H; Kuwano H
Int J Clin Oncol; 2021 Dec; 26(12):2255-2264. PubMed ID: 34519930
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
[TBL] [Abstract][Full Text] [Related]
39. Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy.
Gur I; Diggs BS; Wagner JA; Vaccaro GM; Lopez CD; Sheppard BC; Orloff SL; Billingsley KG
J Gastrointest Surg; 2013 Dec; 17(12):2133-42. PubMed ID: 24091909
[TBL] [Abstract][Full Text] [Related]
40. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases.
Liu M; Bao Q; Zhao T; Huang L; Zhang D; Wang Y; Yan X; Wang H; Jin K; Liu W; Wang K; Xing B
Hepatol Int; 2024 Jun; 18(3):1029-1039. PubMed ID: 38427145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
